All News about Morphosys Ag ADR
MorphoSys' Licensing Partner Roche Received Breakthrough Therapy Designation for Gantenerumab in Alzheimer's Disease
October 11, 2021
From MorphoSys AG
Via AccessWire
Exposures
Product Safety
Via Benzinga
Exposures
Product Safety
Via Benzinga
Via Benzinga
Via Benzinga
MorphoSys AG (MOR) Q2 2021 Earnings Call Transcript
July 31, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|